Similar articles

• Reduction of thyroid nodule volume by levothyroxine and iodine alone and in combination: a randomized, placebo-controlled trial.

  Grussendorf M, Reiners C, Paschke R, Wegscheider K; LISA Investigators. Grussendorf M, et al. J Clin Endocrinol Metab. 2011 Sep;96(9):2786-95. doi: 10.1210/jc.2011-0356. Epub 2011 Jun 29. J Clin Endocrinol Metab. 2011. PMID: 21715542 Free PMC article. Clinical Trial.
• [Pathophysiologic basis for prevention and pharmacotherapy of benign cold thyroid nodules].

  Brauer VF, Paschke R. Brauer VF, et al. Dtsch Med Wochenschr. 2003 Oct 31;128(44):2324-8. doi: 10.1055/s-2003-43189. Dtsch Med Wochenschr. 2003. PMID: 14593577 Review. German. No abstract available.
• Thyroxine suppressive therapy in patients with nodular thyroid disease.

  Gharib H, Mazzaferri EL. Gharib H, et al. Ann Intern Med. 1998 Mar 1;128(5):386-94. doi: 10.7326/0003-4819-128-5-199803010-00008. Ann Intern Med. 1998. PMID: 9490600 Review.
• Thyroid-hormone-suppressive therapy in benign thyroid nodules.

  Helling TJ. Helling TJ. Lancet. 2003 Mar 29;361(9363):1137. doi: 10.1016/S0140-6736(03)12882-6. Lancet. 2003. PMID: 12672348 No abstract available.
• [Thyroxine therapy in benign thyroid nodules].

  Vulpoi C, Zbranca E, Mogoş V, Preda C, Găleşanu C, Ungureanu MC, Ciobanu DG, Brănişteanu DD. Vulpoi C, et al. Rev Med Chir Soc Med Nat Iasi. 2001 Jan-Mar;105(1):95-100. Rev Med Chir Soc Med Nat Iasi. 2001. PMID: 12092166 Romanian.